TELA Bio, Inc.
TELA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $69,300 | $58,453 | $41,418 | $29,463 |
| % Growth | 18.6% | 41.1% | 40.6% | – |
| Cost of Goods Sold | $22,812 | $18,341 | $14,374 | $10,650 |
| Gross Profit | $46,488 | $40,112 | $27,044 | $18,813 |
| % Margin | 67.1% | 68.6% | 65.3% | 63.9% |
| R&D Expenses | $8,813 | $9,619 | $8,937 | $6,743 |
| G&A Expenses | $14,722 | $14,887 | $13,862 | $12,459 |
| SG&A Expenses | $79,370 | $74,568 | $57,114 | $41,521 |
| Sales & Mktg Exp. | $64,648 | $59,681 | $43,252 | $29,062 |
| Other Operating Expenses | -$7,580 | $0 | $0 | $0 |
| Operating Expenses | $80,603 | $84,187 | $66,051 | $48,264 |
| Operating Income | -$34,115 | -$44,075 | -$39,007 | -$29,451 |
| % Margin | -49.2% | -75.4% | -94.2% | -100% |
| Other Income/Exp. Net | -$3,870 | -$2,589 | -$5,289 | -$3,825 |
| Pre-Tax Income | -$37,985 | -$46,664 | -$44,296 | -$33,276 |
| Tax Expense | -$144 | $0 | $0 | $0 |
| Net Income | -$37,841 | -$46,664 | -$44,296 | -$33,276 |
| % Margin | -54.6% | -79.8% | -106.9% | -112.9% |
| EPS | -1.33 | -2.04 | -2.73 | -2.3 |
| % Growth | 34.8% | 25.3% | -18.7% | – |
| EPS Diluted | -1.33 | -2.04 | -2.73 | -2.3 |
| Weighted Avg Shares Out | 28,526 | 22,869 | 16,268 | 14,473 |
| Weighted Avg Shares Out Dil | 28,526 | 22,869 | 16,268 | 14,473 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5,290 | $5,223 | $4,051 | $3,597 |
| Depreciation & Amortization | $1,012 | $808 | $1,187 | $535 |
| EBITDA | -$31,683 | -$40,633 | -$39,058 | -$29,144 |
| % Margin | -45.7% | -69.5% | -94.3% | -98.9% |